Let’s look at the key reasons that are pushing Amylyx Pharmaceuticals Inc (AMLX) to new highs

On Friday, Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) was 7.08% up from the session before settling in for the closing price of $4.52. A 52-week range for AMLX has been $1.58 – $7.27.

Healthcare Sector giant saw their annual sales surged by 1825.06% over the last five years. When this article was written, the company’s average yearly earnings per share was at 60.59%. With a float of $65.31 million, this company’s outstanding shares have now reached $89.08 million.

The firm has a total of 123 workers. Let’s measure their productivity. In terms of profitability, gross margin is 775.71%, operating margin of 16317.06%, and the pretax margin is 17255.66%.

Amylyx Pharmaceuticals Inc (AMLX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Amylyx Pharmaceuticals Inc stocks. The insider ownership of Amylyx Pharmaceuticals Inc is 26.74%, while institutional ownership is 76.78%. The most recent insider transaction that took place on Mar 31 ’25, was worth 37,806. In this transaction Chief Financial Officer of this company sold 10,896 shares at a rate of $3.47, taking the stock ownership to the 290,988 shares. Before that another transaction happened on Mar 31 ’25, when Company’s Chief Medical Officer sold 12,425 for $3.47, making the entire transaction worth $43,082. This insider now owns 194,375 shares in total.

Amylyx Pharmaceuticals Inc (AMLX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 60.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.16% during the next five years compared to -78.71% drop over the previous five years of trading.

Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators

You can see what Amylyx Pharmaceuticals Inc (AMLX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 12.05.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.10, a number that is poised to hit -0.44 in the next quarter and is forecasted to reach -1.46 in one year’s time.

Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)

Analysing the last 5-days average volume posted by the [Amylyx Pharmaceuticals Inc, AMLX], we can find that recorded value of 0.74 million was lower than the volume posted last year of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 31.88%. Additionally, its Average True Range was 0.40.

During the past 100 days, Amylyx Pharmaceuticals Inc’s (AMLX) raw stochastic average was set at 75.93%, which indicates a significant increase from 47.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.69% in the past 14 days, which was lower than the 77.86% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.14, while its 200-day Moving Average is $3.81. Now, the first resistance to watch is $4.97. This is followed by the second major resistance level at $5.11. The third major resistance level sits at $5.36. If the price goes on to break the first support level at $4.59, it is likely to go to the next support level at $4.34. Now, if the price goes above the second support level, the third support stands at $4.20.

Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Key Stats

There are 89,141K outstanding shares of the company, which has a market capitalization of 431.44 million. As of now, sales total 87,370 K while income totals -301,740 K. Its latest quarter income was -660 K while its last quarter net income were -37,550 K.